Dow Q2 2026 Sales Jump 20% YoY but Restructuring, Leverage Loom Large

What happened

Dow reported Q2 2026 net sales of $12.1B, up 20% year-over-year across all segments, signaling a cyclical recovery. However, the company is still digging out from a brutal 2025 net loss of $2.6B and negative free cash flow, with net debt/EBITDA at 14x. The 'Transform to Outperform' program targets $2B EBITDA uplift by 2028, but only early benefits are visible in Q2, with restructuring costs still weighing on cash flow. Management guided for only modest sequential rebound, and high leverage leaves little room for error if demand falters. Investors should focus on EBITDA realization and cash conversion rather than top-line growth, as the equity remains a high-risk turnaround bet.

Implication

The 20% sales growth confirms volume and pricing normalization, but it is not yet translating into sustainable earnings or free cash flow, given heavy restructuring outlays. With net debt/EBITDA still elevated, the balance sheet remains stretched, constraining management's ability to invest or return capital. The Transform to Outperform program is on track, but investors should expect noisy quarters with lumpy charges; the real test is whether Operating EBITDA can exceed $5B by 2027. Risk of another dividend cut or equity raise remains if cost savings disappoint or industry recovery stalls, so a margin of safety is lacking at current prices. Patient investors should wait for two to three quarters of demonstrated EBITDA improvement and positive free cash flow before considering entry, as the upside is contingent on flawless execution.

Thesis delta

The strong Q2 revenue growth suggests cyclical recovery is underway earlier than anticipated, which could accelerate EBITDA improvement and reduce leverage. However, the core thesis remains that the equity embeds significant execution risk, and we need to see cost savings materialize. The delta is a modest increase in confidence that the cyclical trough may be behind, but we still require proof of cash generation and leverage reduction.